These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67. Are switches from oral to subcutaneous methotrexate or addition of ciclosporin to methotrexate useful steps in a tight control treatment strategy for rheumatoid arthritis? A post hoc analysis of the CAMERA study. Bakker MF; Jacobs JW; Welsing PM; van der Werf JH; Linn-Rasker SP; van der Veen MJ; Lafeber FP; Bijlsma JW; Ann Rheum Dis; 2010 Oct; 69(10):1849-52. PubMed ID: 20511610 [TBL] [Abstract][Full Text] [Related]
68. Efficacy and safety of low-dose tacrolimus for active rheumatoid arthritis with an inadequate response to methotrexate. Lee WS; Lee SI; Lee MS; Kim SI; Lee SS; Yoo WH Korean J Intern Med; 2016 Jul; 31(4):779-87. PubMed ID: 26961485 [TBL] [Abstract][Full Text] [Related]
69. Bioavailability of higher dose MTX comparing oral and subcutaneous administration in patients with RA. Rau R J Rheumatol; 2005 Jul; 32(7):1412; author reply 1412-3. PubMed ID: 15996092 [No Abstract] [Full Text] [Related]
70. The presence of HLA-DR B1 shared motif does not influence cyclophosphamide and methotrexate cytotoxicity in rheumatoid arthritis patients. Lacki JK; Wassmuth R; Korczowska I; Mackiewicz S; Muller W J Investig Allergol Clin Immunol; 2000; 10(4):235-41. PubMed ID: 11039841 [TBL] [Abstract][Full Text] [Related]
71. [Therapy of rheumatoid arthritis with etanercept]. Lamprecht P; Nitschmann S Internist (Berl); 2009 May; 50(5):633-4. PubMed ID: 19350212 [No Abstract] [Full Text] [Related]
72. Subtherapeutic dosing of methotrexate in rheumatoid arthritis trials. Parker CT; Mewshaw E; Dennis GJ J Am Osteopath Assoc; 2004 Jan; 104(1):7-8. PubMed ID: 14992316 [No Abstract] [Full Text] [Related]
73. [Security of the combined treatment of methotrexate and leflunomide in patients with rheumatoid arthritis]. Nesa L; Gobbi C; Alba P; Exeni I; Babini A; Albiero E Rev Fac Cien Med Univ Nac Cordoba; 2007; 64(4):109-14. PubMed ID: 19928400 [TBL] [Abstract][Full Text] [Related]
75. Pneumocystis jiroveci pneumonia associated with low-dose methotrexate treatment for rheumatoid arthritis: report of two cases and review of the literature. Kaneko Y; Suwa A; Ikeda Y; Hirakata M Mod Rheumatol; 2006; 16(1):36-8. PubMed ID: 16622722 [TBL] [Abstract][Full Text] [Related]
76. Long-term safety of methotrexate in the treatment of rheumatoid arthritis. Yazici Y Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S65-7. PubMed ID: 21044436 [TBL] [Abstract][Full Text] [Related]
77. Purulent pericarditis in a patient with rheumatoid arthritis treated with etanercept and methotrexate. Sweet DD; Isac G; Morrison B; Fenwick J; Dhingra V CJEM; 2007 Jan; 9(1):40-2. PubMed ID: 17391602 [TBL] [Abstract][Full Text] [Related]
78. Investigation of the chronic pulmonary effects of low-dose oral methotrexate in patients with rheumatoid arthritis: a prospective study incorporating HRCT scanning and pulmonary function tests. Dawson JK; Graham DR; Desmond J; Fewins HE; Lynch MP Rheumatology (Oxford); 2002 Mar; 41(3):262-7. PubMed ID: 11934961 [TBL] [Abstract][Full Text] [Related]
79. High Methotrexate Triglutamate Level Is an Independent Predictor of Adverse Effects in Asian Indian Rheumatoid Arthritis Patients-A Preliminary Study. Sandhu A; Dhir V; Bhatnagar A; Dhawan V; Kaur J; Sood A; Naidu S; Ahmad S; Varma N; Sharma A; Sharma S Ther Drug Monit; 2017 Apr; 39(2):157-163. PubMed ID: 28107255 [TBL] [Abstract][Full Text] [Related]
80. Methotrexate polyglutamate concentrations are not associated with disease control in rheumatoid arthritis patients receiving long-term methotrexate therapy. Stamp LK; O'Donnell JL; Chapman PT; Zhang M; James J; Frampton C; Barclay ML Arthritis Rheum; 2010 Feb; 62(2):359-68. PubMed ID: 20112376 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]